• Corrective Action and Preventive Actions Muhammad Asim Niazi
    February 19, 2024
    Corrective Action & Preventive Action in the pharma industry is more than a regulatory and standardization requirement.
  • Case study of FDA warning letters Muhammad Asim Niazi
    January 23, 2024
    A warning letter is a part of communication by the FDA with the manufacturer to share their finding to remove the discrepancy found during their inspection and inform the status of the manufacturer's measures.
PharmaSources Customer Service